LASP-1 is overexpressed in several human malignancies included human metastatic breast cancer, ovarian cancer, colorectal cancer, malignant childhood medulloblastoma, hepatocellular carcinoma, bladder and oral cancer, and prostate carcinoma (9–15). Here, LASP1 is linked to prostate carcinoma.